(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.
The three biggest winners today are Signature Bank, SeaChange International, and Sangamo Therapeutics.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Signature Bank (SBNY) | 1.85 | 68.18% | 2023-12-28 21:13:05 |
| 2 | SeaChange International (SEAC) | 3.12 | 13.64% | 2023-12-28 22:55:27 |
| 3 | Sangamo Therapeutics (SGMO) | 0.60 | 11.55% | 2023-12-28 23:15:05 |
| 4 | Origin Agritech Limited (SEED) | 2.51 | 10.74% | 2023-12-28 23:06:06 |
| 5 | Stanley Furniture Company (STLY) | 6.24 | 9.42% | 2023-12-29 07:07:05 |
| 6 | comScore (SCOR) | 15.30 | 9.21% | 2023-12-28 22:23:07 |
| 7 | SCYNEXIS (SCYX) | 2.17 | 9.05% | 2023-12-28 22:44:06 |
| 8 | Synchronoss Technologies (SNCR) | 6.29 | 8.45% | 2023-12-29 03:14:05 |
| 9 | EchoStar Corporation (SATS) | 16.08 | 6.63% | 2023-12-28 21:07:05 |
| 10 | NetEase (NTES) | 93.64 | 4.86% | 2023-12-29 12:13:53 |
The three biggest losers today are Canaan, Marathon, and Riot Blockchain.
| Rank | Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|---|
| 1 | Canaan (CAN) | 2.33 | -17.13% | 2023-12-29 12:15:50 |
| 2 | Marathon (MARA) | 23.84 | -15.19% | 2023-12-29 12:13:27 |
| 3 | Riot Blockchain (RIOT) | 15.37 | -12.65% | 2023-12-29 12:16:55 |
| 4 | Tenax Therapeutics (TENX) | 0.29 | -10.67% | 2023-12-29 10:17:06 |
| 5 | Xenetic Biosciences (XBIO) | 3.28 | -8.89% | 2023-12-29 12:17:34 |
| 6 | Bionano Genomics (BNGO) | 1.92 | -7.04% | 2023-12-29 12:15:46 |
| 7 | Coinbase (COIN) | 173.80 | -6.74% | 2023-12-29 13:00:59 |
| 8 | Streamline Health Solutions (STRM) | 0.45 | -6.41% | 2023-12-29 07:10:05 |
| 9 | 2U (TWOU) | 1.23 | -6.11% | 2023-12-29 14:23:05 |
| 10 | MicroStrategy (MSTR) | 627.39 | -6.06% | 2023-12-29 12:13:41 |
Winners today
1. Signature Bank (SBNY) – 68.18%
Signature Bank provides commercial banking products and services. It accepts various deposit products, including checking accounts, money market accounts, escrow deposit accounts, cash concentration accounts, certificates of deposit, and other cash management products. The company provides various lending products comprising commercial and industrial loans, real estate loans, and letters of credit. In addition, it offers asset management and investment products; and retirement products, such as individual retirement accounts and administrative services for retirement vehicles. Further, the company provides wealth management services to its high net worth personal clients; and purchases, sells, and assembles small business administration loans and pools. Additionally, it offers individual and group insurance products, including health, life, disability, and long-term care insurance products for business and private clients. As of December 31, 2021, the company operated 37 private client offices located in the metropolitan New York area, Connecticut, California, and North Carolina. Signature Bank was incorporated in 2000 and is headquartered in New York, New York.
NASDAQ ended the session with Signature Bank rising 68.18% to $1.85 on Friday, after five sequential sessions in a row of gains. NASDAQ slid 0.56% to $15,011.35, following the last session’s downward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Signature Bank has a trailing twelve months EPS of $20.76.
PE Ratio
Signature Bank has a trailing twelve months price to earnings ratio of 0.09. Meaning, the purchaser of the share is investing $0.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.87%.
Yearly Top and Bottom Value
Signature Bank’s stock is valued at $1.85 at 16:32 EST, way below its 52-week high of $149.72 and way higher than its 52-week low of $0.00.
Volume
Today’s last reported volume for Signature Bank is 2399600 which is 434.54% above its average volume of 448906.
Moving Average
Signature Bank’s value is way above its 50-day moving average of $0.17 and way above its 200-day moving average of $0.82.
More news about Signature Bank.
2. SeaChange International (SEAC) – 13.64%
SeaChange International, Inc. provides multiscreen, advertising, and premium over the top (OTT) video products and services that facilitate the aggregation, licensing, management, and distribution of video and advertising content worldwide. The company offers video products, including video back-office, a software platform that enables content and service providers to manage, monetize and deliver a seamless viewing experience to subscribers across televisions, personal computers (PCs), tablets, smart phones, and other IP-enabled devices; and media asset management software, which is used to receive, manage and publish video content for viewing on televisions, tablets, PCs and other consumer devices. It also provides an advertising platform to maximize advertising revenue across multiscreen, broadcast, on-demand, and OTT viewing. In addition, the company offers client application, a multiscreen user experience product that empower service providers and content owners to optimize live and on-demand video consumption on multiscreen and OTT services. Further, it provides professional, and maintenance and technical support services, as well as managed services. The company sells and markets its products and services through a direct sales process, as well as to systems integrators and value-added resellers. It serves cable system operators, telecommunications companies, and satellite operators, as well as broadcasters and other content providers. The company was incorporated in 1993 and is headquartered in Boston, Massachusetts.
NASDAQ ended the session with SeaChange International rising 13.64% to $3.12 on Friday while NASDAQ dropped 0.56% to $15,011.35.
Earnings Per Share
As for profitability, SeaChange International has a trailing twelve months EPS of $-3.67.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.07%.
Sales Growth
SeaChange International’s sales growth is 12% for the present quarter and 8% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4%, now sitting on 32.76M for the twelve trailing months.
Yearly Top and Bottom Value
SeaChange International’s stock is valued at $3.12 at 16:32 EST, way under its 52-week high of $11.00 and way higher than its 52-week low of $1.50.
More news about SeaChange International.
3. Sangamo Therapeutics (SGMO) – 11.55%
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucleases, which are proteins used in modifying DNA sequences by adding or knocking out specific genes; and ZFP transcription factors proteins used in increasing or decreasing gene expression. It develops SB-525, which is in Phase III AFFINE clinical trial for the treatment of hemophilia A; ST-920, a gene therapy, which is in Phase I/II STAAR clinical trials for the treatment of Fabry disease; and SAR445136, a cell therapy, which is in Phase I/II PRECIZN-1 clinical trials for the treatment of sickle cell disease. The company also develops TX200, chimeric antigen receptor for the treatment of HLA-A2 mismatched kidney transplant rejection; KITE-037, a cell therapy for the treatment of cancer; ST-501 for the treatment of tauopathies; and ST-502 for the treatment of synucleinopathies, including Parkinson's disease and neuromuscular disease. It has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; Open Monoclonal Technology, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and California Institute for Regenerative Medicine. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. Sangamo Therapeutics, Inc. was incorporated in 1995 and is headquartered in Brisbane, California.
NASDAQ ended the session with Sangamo Therapeutics rising 11.55% to $0.60 on Friday while NASDAQ slid 0.56% to $15,011.35.
Earnings Per Share
As for profitability, Sangamo Therapeutics has a trailing twelve months EPS of $-1.46.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -112.37%.
Sales Growth
Sangamo Therapeutics’s sales growth is negative 70.3% for the present quarter and negative 94.7% for the next.
More news about Sangamo Therapeutics.
4. Origin Agritech Limited (SEED) – 10.74%
Origin Agritech Limited, together with its subsidiaries, operates an agricultural biotechnology and an e-commerce platform in the People's Republic of China. The company engages in crop seed breeding and genetic improvement activities. It develops, produces, and distributes hybrid crop seeds, as well as develops hybrid seed technology. The company also operates an e-commerce platform, which provides range of products, including agricultural seed products that comprise corn, rice, and vegetable seeds; other agricultural inputs, such as fertilizers and agricultural chemicals; foods; household products; and other consumer products to farmers through online and mobile ordering. It has a collaboration agreement with Chinese Academy of Agricultural Sciences, the National Maize Improvement Center, China Agricultural University, and Zhejiang University. Origin Agritech Limited was founded in 1997 and is headquartered in Beijing, China.
NASDAQ ended the session with Origin Agritech Limited rising 10.74% to $2.51 on Friday while NASDAQ fell 0.56% to $15,011.35.
Earnings Per Share
As for profitability, Origin Agritech Limited has a trailing twelve months EPS of $-0.21.
Yearly Top and Bottom Value
Origin Agritech Limited’s stock is valued at $2.51 at 16:32 EST, way below its 52-week high of $10.66 and way above its 52-week low of $1.63.
Volume
Today’s last reported volume for Origin Agritech Limited is 134489 which is 435.23% above its average volume of 25127.
Moving Average
Origin Agritech Limited’s value is above its 50-day moving average of $2.30 and way below its 200-day moving average of $4.10.
More news about Origin Agritech Limited.
5. Stanley Furniture Company (STLY) – 9.42%
HG Holdings, Inc., through its interest in HC Government Realty Trust, Inc., owns and operates real estate properties in the United States. It owns and operates a portfolio of 20 single-tenant properties leased for the occupancy by federal agencies, including the Federal Bureau of Investigation, the Drug Enforcement Administration, the Social Security Administration, and the Department of Transportation. The company was formerly known as Stanley Furniture Company, Inc. and changed its name to HG Holdings, Inc. in March 2018. HG Holdings, Inc. was incorporated in 1984 and is headquartered in Charlotte, North Carolina.
NASDAQ ended the session with Stanley Furniture Company jumping 9.42% to $6.24 on Friday, following the last session’s upward trend. NASDAQ slid 0.56% to $15,011.35, following the last session’s downward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, Stanley Furniture Company has a trailing twelve months EPS of $0.48.
PE Ratio
Stanley Furniture Company has a trailing twelve months price to earnings ratio of 12.99. Meaning, the purchaser of the share is investing $12.99 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.76%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Stanley Furniture Company’s EBITDA is 0.6.
Revenue Growth
Year-on-year quarterly revenue growth declined by 49.7%, now sitting on 13.81M for the twelve trailing months.
Yearly Top and Bottom Value
Stanley Furniture Company’s stock is valued at $6.24 at 16:32 EST, way under its 52-week high of $8.25 and way higher than its 52-week low of $5.07.
Moving Average
Stanley Furniture Company’s value is above its 50-day moving average of $5.94 and below its 200-day moving average of $6.72.
More news about Stanley Furniture Company.
6. comScore (SCOR) – 9.21%
comScore, Inc. operates as an information and analytics company that measures advertising, consumer behavior, and audiences across media platforms in the United States, Europe, Latin America, Canada, and internationally. The company offers ratings and planning products and services, including Media Metrix Multi-Platform and Mobile Metrix, which measure Websites and apps on computers, smartphones, and tablets; Video Metrix that delivers measurement of digital video consumption; Plan Metrix, which offers understanding of consumer lifestyle; TV Essentials that combines TV viewing information with marketing segmentation and consumer databases; and StationView Essentials to understand consumer viewing patterns and characteristics. Its ratings and planning products and services also comprises Cross-Platform solutions, including Comscore Campaign Ratings for verification of mobile and desktop video campaigns; OnDemand Essentials that provides transactional tracking and reporting; validated Campaign Essentials, which validates whether digital ad impressions are visible to humans, identifies those that are fraudulent, and verifies that ads are shown in brand safe content and delivered to the right audience targets; and Total Home Panel Suite, which capture OTT, connected TV, and IOT device usage and content consumption. In addition, the company offers analytics and optimization products and services that provide solutions for planning, optimization, and evaluation of advertising campaigns and brand protection. Further, it provides movies reporting and analytics products and services to measure movie viewership and box office results by capturing movie ticket sales in real time or near real time. The company serves digital publishers, television networks, movie studios, content owners, brand advertisers, agencies, and technology providers. comScore, Inc. was incorporated in 1999 and is headquartered in Reston, Virginia.
NASDAQ ended the session with comScore jumping 9.21% to $15.30 on Friday, after two consecutive sessions in a row of gains. NASDAQ fell 0.56% to $15,011.35, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, comScore has a trailing twelve months EPS of $-14.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -16.85%.
More news about comScore.
7. SCYNEXIS (SCYX) – 9.05%
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections; and ibrexafungerp that has completed Phase 3 CANDLE study for the prevention of recurrent (VVC). It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
NASDAQ ended the session with SCYNEXIS jumping 9.05% to $2.17 on Friday, after three successive sessions in a row of gains. NASDAQ dropped 0.56% to $15,011.35, following the last session’s downward trend on what was a somewhat bearish trend trading session today.
Earnings Per Share
As for profitability, SCYNEXIS has a trailing twelve months EPS of $1.49.
PE Ratio
SCYNEXIS has a trailing twelve months price to earnings ratio of 1.46. Meaning, the purchaser of the share is investing $1.46 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 132.23%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
SCYNEXIS’s EBITDA is 0.01.
Revenue Growth
Year-on-year quarterly revenue growth grew by 13.1%, now sitting on 135.87M for the twelve trailing months.
More news about SCYNEXIS.
8. Synchronoss Technologies (SNCR) – 8.45%
Synchronoss Technologies, Inc. provides cloud, digital, messaging, and network management platforms, products, and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Its platforms, products, and solutions include cloud sync, backup, storage, device set up, content transfer, and content engagement for user generated content; multi-channel messaging peer-to-peer communications and application-to-person commerce solutions; customer journey and workflow design, development, orchestration, and experience management solutions; and telecom network infrastructure designing, procuring, managing, and optimizing solutions. In addition, the company offers software development and customization services. It markets and sells its services through direct sales force and strategic partners. Synchronoss Technologies, Inc. was incorporated in 2000 and is headquartered in Bridgewater, New Jersey.
NASDAQ ended the session with Synchronoss Technologies jumping 8.45% to $6.29 on Friday, after three successive sessions in a row of gains. NASDAQ slid 0.56% to $15,011.35, following the last session’s downward trend on what was a somewhat down trend exchanging session today.
Earnings Per Share
As for profitability, Synchronoss Technologies has a trailing twelve months EPS of $-4.68.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.88%.
Sales Growth
Synchronoss Technologies’s sales growth is negative 30.5% for the current quarter and negative 27.7% for the next.
Volume
Today’s last reported volume for Synchronoss Technologies is 100916 which is 68.78% above its average volume of 59790.
Yearly Top and Bottom Value
Synchronoss Technologies’s stock is valued at $6.29 at 16:32 EST, way below its 52-week high of $10.53 and way above its 52-week low of $2.70.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 87.5% and 62.5%, respectively.
More news about Synchronoss Technologies.
9. EchoStar Corporation (SATS) – 6.63%
EchoStar Corporation, together with its subsidiaries, provides networking technologies and services worldwide. The company operates in two segments, Hughes and EchoStar Satellite Services (ESS). The Hughes segment offers broadband network technologies, managed services, equipment, hardware, satellite services, and communications solutions to government and enterprise customers. The segment also designs, provides, and installs gateway and terminal equipment to customers for other satellite systems. In addition, it designs, develops, constructs, and provides telecommunication networks comprising satellite ground segment systems and terminals to mobile system operators and enterprise customers. Further, this segment designs, provides, and installs gateway and terminal equipment to customers for other satellite systems, as well as offers satellite ground segment systems and terminals for other satellite systems, including mobile system operators. The ESS segment provides satellite services using its owned and leased in-orbit satellites and related licenses to offer satellite services on a full-time and/or occasional-use basis to the U.S. government service providers, internet service providers, broadcast news organizations, content providers, and private enterprise customers. It serves customers in North America, South and Central America, Asia, Africa, Australia, Europe, India, and the Middle East. The company was incorporated in 2007 and is headquartered in Englewood, Colorado.
NASDAQ ended the session with EchoStar Corporation rising 6.63% to $16.08 on Friday, after five sequential sessions in a row of gains. NASDAQ dropped 0.56% to $15,011.35, following the last session’s downward trend on what was a somewhat negative trend trading session today.
Earnings Per Share
As for profitability, EchoStar Corporation has a trailing twelve months EPS of $1.11.
PE Ratio
EchoStar Corporation has a trailing twelve months price to earnings ratio of 14.49. Meaning, the purchaser of the share is investing $14.49 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.36%.
Moving Average
EchoStar Corporation’s worth is way higher than its 50-day moving average of $12.35 and below its 200-day moving average of $16.34.
Yearly Top and Bottom Value
EchoStar Corporation’s stock is valued at $16.08 at 16:32 EST, way under its 52-week high of $24.80 and way above its 52-week low of $9.53.
Sales Growth
EchoStar Corporation’s sales growth is negative 6.2% for the ongoing quarter and 1.1% for the next.
Volume
Today’s last reported volume for EchoStar Corporation is 2759710 which is 195.15% above its average volume of 935003.
More news about EchoStar Corporation.
10. NetEase (NTES) – 4.86%
NetEase, Inc. engages in online games, music streaming, online intelligent learning services, and internet content services businesses in China and internationally . The company operates through Games and Related Value-Added Services, Youdao, Cloud Music, and Innovative Businesses and Others segments. It develops and operates PC and mobile games, as well as offers games licensed from other game developers. The company's products and services include Youdao Dictionary, an online knowledge tool; Youdao Translation, a tool specifically designed to support translation needs of business and leisure travelers; U-Dictionary, an online dictionary and translation app; Youdao Kids' Dictionary, a smart and fun tool; smart devices, such as Youdao Dictionary Pen, Youdao Smart Learning Pad, Youdao Listening Pod, Youdao Smart Light, Youdao Pocket Translator, and Youdao Super Dictionary; online courses; interactive learning apps; and education digitalization solutions, such as Youdao Smart Learning Terminal, a device that automates paper-based homework processing; Youdao Smart Cloud, a cloud-based platform that allows third-party app developers, smart device brands, and manufacturers to the company's OCR capabilities; and Youdao Sports, a sports-centric educational system. Its products and services also include NetEase Cloud Music, a music streaming platform; Yanxuan, an e-commerce platform, which sells private label products; www.163.com portal and related mobile app, Wangyi Xinwen, which deliver information such as news, sports events, technology, fashion trends, and online entertainment; NetEase Mail, an email service; NetEase CC Live streaming, a live streaming platform with a focus on game broadcasting; and NetEase Pay, a payment platform. The company was formerly known as NetEase.com, Inc. and changed its name to NetEase, Inc. in March 2012. NetEase, Inc. was founded in 1997 and is headquartered in Hangzhou, the People's Republic of China.
NASDAQ ended the session with NetEase rising 4.86% to $93.64 on Friday while NASDAQ slid 0.56% to $15,011.35.
Earnings Per Share
As for profitability, NetEase has a trailing twelve months EPS of $5.76.
PE Ratio
NetEase has a trailing twelve months price to earnings ratio of 16.26. Meaning, the purchaser of the share is investing $16.26 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.68%.
Volume
Today’s last reported volume for NetEase is 3335570 which is 89.41% above its average volume of 1760960.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 61.7% and 8.6%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 11.6%, now sitting on 101.68B for the twelve trailing months.
Volatility
NetEase’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.01%, a negative 1.46%, and a positive 1.75%.
NetEase’s highest amplitude of average volatility was 5.21% (last week), 2.75% (last month), and 1.75% (last quarter).
More news about NetEase.
Losers Today
1. Canaan (CAN) – -17.13%
Canaan Inc. engages in the research, design, and sale of integrated circuit (IC) final mining equipment products by integrating IC products for bitcoin mining and related components in the People's Republic of China. It is also involved in the assembly and distribution of mining equipment and spare parts. The company has operations in the United States, Australia, Kazakhstan, Hong Kong, Canada, Mainland China, Thailand, Sweden, and internationally. Canaan Inc. was founded in 2013 and is based in Singapore.
NASDAQ ended the session with Canaan sliding 17.13% to $2.33 on Friday while NASDAQ fell 0.56% to $15,011.35.
Earnings Per Share
As for profitability, Canaan has a trailing twelve months EPS of $-0.47.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.23%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Canaan’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for Canaan is 32233800 which is 273.29% above its average volume of 8634860.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Canaan’s EBITDA is 1.03.
More news about Canaan.
2. Marathon (MARA) – -15.19%
Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.
NASDAQ ended the session with Marathon sliding 15.19% to $23.84 on Friday, following the last session’s downward trend. NASDAQ slid 0.56% to $15,011.35, following the last session’s downward trend on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, Marathon has a trailing twelve months EPS of $-3.08.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.13%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Marathon’s EBITDA is 23.81.
Yearly Top and Bottom Value
Marathon’s stock is valued at $23.84 at 16:32 EST, way below its 52-week high of $27.73 and way higher than its 52-week low of $3.11.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 90.6% and 180%, respectively.
More news about Marathon.
3. Riot Blockchain (RIOT) – -12.65%
Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. It operates through Bitcoin Mining, Data Center Hosting, and Engineering segments. The company also provides co-location services for institutional-scale bitcoin mining companies; and critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners. In addition, it engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy; operation of data centers; and maintenance/management of computing capacity. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.
NASDAQ ended the session with Riot Blockchain falling 12.65% to $15.37 on Friday while NASDAQ slid 0.56% to $15,011.35.
Earnings Per Share
As for profitability, Riot Blockchain has a trailing twelve months EPS of $-1.8.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.88%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Riot Blockchain’s stock is considered to be oversold (<=20).
Sales Growth
Riot Blockchain’s sales growth is 46.6% for the present quarter and 38.6% for the next.
More news about Riot Blockchain.
4. Tenax Therapeutics (TENX) – -10.67%
Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. The company develops levosimendan, which completed a phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction; and Imatinib, a tyrosine kinase inhibitor for the treatment of pulmonary arterial hypertension. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.
NASDAQ ended the session with Tenax Therapeutics sliding 10.67% to $0.29 on Friday, after two consecutive sessions in a row of gains. NASDAQ slid 0.56% to $15,011.35, following the last session’s downward trend on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, Tenax Therapeutics has a trailing twelve months EPS of $-1.11.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -92.3%.
Volume
Today’s last reported volume for Tenax Therapeutics is 1580990 which is 78.27% below its average volume of 7278670.
More news about Tenax Therapeutics.
5. Xenetic Biosciences (XBIO) – -8.89%
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.
NASDAQ ended the session with Xenetic Biosciences sliding 8.89% to $3.28 on Friday while NASDAQ fell 0.56% to $15,011.35.
Earnings Per Share
As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-2.9.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -34.98%.
Sales Growth
Xenetic Biosciences’s sales growth for the current quarter is 39.9%.
Volatility
Xenetic Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was 2.18%, 0.37%, and 4.60%.
Xenetic Biosciences’s highest amplitude of average volatility was 2.18% (last week), 4.82% (last month), and 4.60% (last quarter).
More news about Xenetic Biosciences.
6. Bionano Genomics (BNGO) – -7.04%
Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.
NASDAQ ended the session with Bionano Genomics sliding 7.04% to $1.92 on Friday, following the last session’s downward trend. NASDAQ fell 0.56% to $15,011.35, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, Bionano Genomics has a trailing twelve months EPS of $-7.17.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -113.43%.
More news about Bionano Genomics.
7. Coinbase (COIN) – -6.74%
Coinbase Global, Inc. provides financial infrastructure and technology for the cryptoeconomy in the United States and internationally. It offers the primary financial account in the cryptoeconomy for consumers; a marketplace with a pool of liquidity for transacting in crypto assets for institutions; and technology and services that enable developers to build crypto-based applications and securely accept crypto assets as payment. The company was founded in 2012 and is based in Wilmington, Delaware.
NASDAQ ended the session with Coinbase dropping 6.74% to $173.80 on Friday while NASDAQ dropped 0.56% to $15,011.35.
Earnings Per Share
As for profitability, Coinbase has a trailing twelve months EPS of $-3.21.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -22.09%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 17.5%, now sitting on 2.58B for the twelve trailing months.
Previous days news about Coinbase
- Why coinbase (coin) stock might be a great pick. According to Zacks on Wednesday, 27 December, "One stock that might be an intriguing choice for investors right now is Coinbase Global, Inc. (COIN Quick QuoteCOIN – Free Report) . "
- An ethereum wallet, purportedly belonging to donald trump, moved $2.4m worth of ETH to coinbase: arkham Intelligence. According to Benzinga on Thursday, 28 December, "Looks like Donald Trump is selling his ETH.3 weeks ago he started sending ETH to Coinbase after months of accumulating Trump NFT royalties. "
More news about Coinbase.
8. Streamline Health Solutions (STRM) – -6.41%
Streamline Health Solutions, Inc. provides health information technology solutions and associated services for hospitals and health systems in the United States and Canada. It provides computer software-based solutions and auditing services, which captures, aggregates, and translates structured and unstructured data to deliver predictive insights. The company also offers coding and clinical documentation improvement (CDI) solutions, which includes integrated cloud-based software suite, CDI, and abstracting and physician query; and eValuator, a cloud-based pre-bill coding analysis platform. In addition, it provides financial management solutions, including accounts receivable management, denials management, claims processing, spend management, and audit management; patient care solutions; and custom integration services for CDI/abstracting, training, and audit services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.
NASDAQ ended the session with Streamline Health Solutions falling 6.41% to $0.45 on Friday while NASDAQ dropped 0.56% to $15,011.35.
Earnings Per Share
As for profitability, Streamline Health Solutions has a trailing twelve months EPS of $-0.35.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -72.37%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Streamline Health Solutions’s EBITDA is 1.4.
Yearly Top and Bottom Value
Streamline Health Solutions’s stock is valued at $0.45 at 16:32 EST, way under its 52-week high of $2.35 and way higher than its 52-week low of $0.21.
Moving Average
Streamline Health Solutions’s value is way higher than its 50-day moving average of $0.35 and way below its 200-day moving average of $1.11.
More news about Streamline Health Solutions.
9. 2U (TWOU) – -6.11%
2U, Inc. operates as an education technology company in the United States, Hong Kong, South Africa, and the United Kingdom. The company operates in two segments, Degree Program and Alternative Credential. The Degree Program segment provides the technology and services to nonprofit colleges and universities to enable the online delivery of degree programs. This segment targets students seeking an undergraduate or graduate degree. The Alternative Credential segment offers online short courses, and technical and skills-based boot camps through nonprofit colleges and universities. This segment targets students seeking to reskill or upskill through shorter duration and lower-priced offerings. It also provides 2UOS, a platform that provides front-end and back-end cloud-based SaaS technology and technology-enabled services. The company was formerly known as 2Tor Inc. and changed its name to 2U, Inc. in October 2012. 2U, Inc. was founded in 2008 and is headquartered in Lanham, Maryland.
NASDAQ ended the session with 2U falling 6.11% to $1.23 on Friday while NASDAQ fell 0.56% to $15,011.35.
Earnings Per Share
As for profitability, 2U has a trailing twelve months EPS of $-3.56.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -76.49%.
Volume
Today’s last reported volume for 2U is 855761 which is 57.98% below its average volume of 2036870.
Revenue Growth
Year-on-year quarterly revenue growth declined by 1.1%, now sitting on 926.34M for the twelve trailing months.
More news about 2U.
10. MicroStrategy (MSTR) – -6.06%
MicroStrategy Incorporated provides enterprise analytics software and services in the United States, Canada, Europe, the Middle East, Africa, and internationally. It offers MicroStrategy, an enterprise analytics software platform that enables users to create visualizations, customize apps, and embed analytics directly into workflows; and MicroStrategy Cloud Environment, a managed software-as-a-service solution, which offers always-on threat monitoring and enables rapid analytics development and deployment to deliver security and data privacy requirements. The company also provides MicroStrategy Support that helps customers to achieve their system availability and uptime goals, and to improve the overall experience through highly responsive troubleshooting and proactive technical product support. In addition, it offers MicroStrategy Consulting, which offers customers with architecture and implementation services to help them quickly realize results, as well as helps to achieve returns on investment derived from understanding of data; and MicroStrategy Education that provides free and paid learning options, as well as holds and acquires bitcoin. The company offers its services through enterprise sales force and channel partners. It serves companies from a range of industries, including banking, technology, consulting, manufacturing, insurance, healthcare, and telecommunications, as well as the public sector. The company was incorporated in 1989 and is headquartered in Tysons Corner, Virginia.
NASDAQ ended the session with MicroStrategy dropping 6.06% to $627.39 on Friday, following the last session’s downward trend. NASDAQ dropped 0.56% to $15,011.35, following the last session’s downward trend on what was a somewhat negative trend exchanging session today.
Earnings Per Share
As for profitability, MicroStrategy has a trailing twelve months EPS of $2.
PE Ratio
MicroStrategy has a trailing twelve months price to earnings ratio of 313.7. Meaning, the purchaser of the share is investing $313.7 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.22%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 3.3%, now sitting on 504.33M for the twelve trailing months.
More news about MicroStrategy.
Stay up to date with our winners and losers daily report
